NITROGLYCERIN
- Product NDC
- 69339-173
- 11-digit product format
- 693390173
- Labeler code
- 69339
- Product ID
- 69339-173_aeb4c868-1d42-4183-b86f-4ae1dc0aa6d3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NITROGLYCERIN
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Labeler
- Natco Pharma USA LLC
- Application
- ANDA211604
- Marketing category
- ANDA
- Marketing start
- 2022-10-03
- Substance
- NITROGLYCERIN
- Active strength
- .3 mg/1
- Pharmacologic classes
- Nitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211604-001 | NITROGLYCERIN | NITROGLYCERIN | 0.3MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | |
| A211604-002 | NITROGLYCERIN | NITROGLYCERIN | 0.4MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | |
| A211604-003 | NITROGLYCERIN | NITROGLYCERIN | 0.6MG | TABLET / SUBLINGUAL | AB | 2019-04-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A211604-001 | AB |
| A211604-002 | AB |
| A211604-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A211604-001 | NITROGLYCERIN | 0.3MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A211604-002 | NITROGLYCERIN | 0.4MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A211604-003 | NITROGLYCERIN | 0.6MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211604-001 | NITROGLYCERIN | 0.3MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211604-002 | NITROGLYCERIN | 0.4MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211604-003 | NITROGLYCERIN | 0.6MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211604-001 | NITROGLYCERIN | 0.3MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211604-002 | NITROGLYCERIN | 0.4MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211604-003 | NITROGLYCERIN | 0.6MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211604-001 | NITROGLYCERIN | 0.3MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211604-002 | NITROGLYCERIN | 0.4MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211604-003 | NITROGLYCERIN | 0.6MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211604-001 | NITROGLYCERIN | 0.3MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211604-002 | NITROGLYCERIN | 0.4MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211604-003 | NITROGLYCERIN | 0.6MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211604-001 | NITROGLYCERIN | 0.3MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211604-002 | NITROGLYCERIN | 0.4MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211604-003 | NITROGLYCERIN | 0.6MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211604-001 | NITROGLYCERIN | 0.3MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211604-002 | NITROGLYCERIN | 0.4MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211604-003 | NITROGLYCERIN | 0.6MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211604-001 | NITROGLYCERIN | 0.3MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211604-002 | NITROGLYCERIN | 0.4MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211604-003 | NITROGLYCERIN | 0.6MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211604-001 | NITROGLYCERIN | 0.3MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211604-002 | NITROGLYCERIN | 0.4MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211604-003 | NITROGLYCERIN | 0.6MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211604-001 | NITROGLYCERIN | 0.3MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211604-002 | NITROGLYCERIN | 0.4MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211604-003 | NITROGLYCERIN | 0.6MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A211604-001 | NITROGLYCERIN | 0.3MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A211604-002 | NITROGLYCERIN | 0.4MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A211604-003 | NITROGLYCERIN | 0.6MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211604-001 | NITROGLYCERIN | 0.3MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211604-002 | NITROGLYCERIN | 0.4MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211604-003 | NITROGLYCERIN | 0.6MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211604-001 | NITROGLYCERIN | 0.3MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211604-002 | NITROGLYCERIN | 0.4MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211604-003 | NITROGLYCERIN | 0.6MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211604-001 | NITROGLYCERIN | 0.3MG | TABLET / SUBLINGUAL | AB | 2019-04-30 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A211604-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A211604-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A211604-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A211604-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A211604-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A211604-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211604-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211604-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211604-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A211604-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A211604-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A211604-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211604-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211604-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211604-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211604-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211604-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211604-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211604-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211604-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211604-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211604-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211604-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211604-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211604-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211604-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211604-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211604-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211604-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211604-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A211604-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A211604-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A211604-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211604-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211604-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211604-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211604-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211604-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211604-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211604-001 | AB | 1 | 1e350fbaab3a… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- NITROGLYCERIN
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| NITROGLYCERIN | .3 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| G59M7S0WS3 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 941ac242-120e-47c1-ac03-50026ff93dd6 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 7480e90b-004b-ebe4-2243-4f2fefdd9e78 | Product name | 2 | 20260128 |
| 3f158398-73f2-4b90-47d1-5c60e8719a98 | Product name | 9 | 20250721 |
| ca6149a6-ded3-9f17-6c41-3e88f2c0c9c0 | Product name | 2 | 20250117 |
| 00358076-c817-430b-b924-11d717dc307c | Product name | 1 | 20160718 |
| 669af5aa-14f3-3df7-f100-5f580ffd43c1 | Product name | 1 | 20140508 |
| 6ff3bab7-2dce-8bea-d7ce-54687f0c01fb | Product name | 1 | 20140508 |
| 8bb82a1c-d0d0-fc27-011f-172e545f0382 | Product name | 1 | 20140508 |
| cb03406d-e223-80bb-67d8-be80f9b6a4f2 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69339-173-01 | NITROGLYCERIN | 1 in 1 CARTON | TABLET | 1 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69339-173-01 | EA - Each | 69339-173 | 04e4ce5d-4a3c-4c1c-bb64-0c9cfdee1e4f | 1 | 2022-10-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NITROGLYCERIN | NITROGLYCERIN | Sportpharm LLC | 84739085-81df-4a43-8456-c9edfbf971e9 | 2026-04-24 | Warnings, Adverse reactions | 211604 ANDA211604 |
| NITROGLYCERIN | NITROGLYCERIN | Redpharm Drug | 3dd022d8-c224-d19f-e063-6394a90adca4 | 2025-09-02 | Warnings, Adverse reactions | 211604 ANDA211604 |
| NITROGLYCERIN | NITROGLYCERIN | NuCare Pharmaceuticals,Inc. | f4ea9ad1-a71f-7cea-e053-2a95a90a106d | 2024-07-22 | Warnings, Adverse reactions | 211604 ANDA211604 |
| NITROGLYCERIN | NITROGLYCERIN | Proficient Rx LP | 160b85ac-d964-463b-9f1e-1429f14ed318 | 2024-02-01 | Warnings, Adverse reactions | 211604 ANDA211604 |
| NITROGLYCERIN | NITROGLYCERIN | Natco Pharma USA LLC | 941ac242-120e-47c1-ac03-50026ff93dd6 | 2023-07-20 | Warnings, Adverse reactions | 211604 ANDA211604 69339-173 |
| NITROGLYCERIN | NITROGLYCERIN | Medical Purchasing Solutions, LL | f9b52553-5a26-d374-e053-6294a90a40c7 | 2023-04-19 | Warnings, Adverse reactions | 211604 ANDA211604 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198038 | nitroglycerin 0.3 MG Sublingual Tablet | PSN | 941ac242-120e-47c1-ac03-50026ff93dd6 | 4 |
| 198039 | nitroglycerin 0.4 MG Sublingual Tablet | PSN | 941ac242-120e-47c1-ac03-50026ff93dd6 | 4 |
| 198040 | nitroglycerin 0.6 MG Sublingual Tablet | PSN | 941ac242-120e-47c1-ac03-50026ff93dd6 | 4 |
| 198038 | nitroglycerin 0.3 MG Sublingual Tablet | SCD | 941ac242-120e-47c1-ac03-50026ff93dd6 | 4 |
| 198039 | nitroglycerin 0.4 MG Sublingual Tablet | SCD | 941ac242-120e-47c1-ac03-50026ff93dd6 | 4 |
| 198040 | nitroglycerin 0.6 MG Sublingual Tablet | SCD | 941ac242-120e-47c1-ac03-50026ff93dd6 | 4 |
| 198038 | nitroglycerin 300 MCG Sublingual Tablet | SY | 941ac242-120e-47c1-ac03-50026ff93dd6 | 4 |
| 198039 | nitroglycerin 400 MCG Sublingual Tablet | SY | 941ac242-120e-47c1-ac03-50026ff93dd6 | 4 |
| 198040 | nitroglycerin 600 MCG Sublingual Tablet | SY | 941ac242-120e-47c1-ac03-50026ff93dd6 | 4 |
| 198038 | NTG 0.3 MG Sublingual Tablet | SY | 941ac242-120e-47c1-ac03-50026ff93dd6 | 4 |
| 198039 | NTG 0.4 MG Sublingual Tablet | SY | 941ac242-120e-47c1-ac03-50026ff93dd6 | 4 |
| 198040 | NTG 0.6 MG Sublingual Tablet | SY | 941ac242-120e-47c1-ac03-50026ff93dd6 | 4 |
| 198038 | TNG 0.3 MG Sublingual Tablet | SY | 941ac242-120e-47c1-ac03-50026ff93dd6 | 4 |
| 198039 | TNG 0.4 MG Sublingual Tablet | SY | 941ac242-120e-47c1-ac03-50026ff93dd6 | 4 |
| 198040 | TNG 0.6 MG Sublingual Tablet | SY | 941ac242-120e-47c1-ac03-50026ff93dd6 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 69339-173-01 | 69339017301 | 1 TABLET in 1 CARTON (69339-173-01) | 1 tablet | 2022-10-03 | 0000-00-00 | No | No | Current |